Exclusive: halt to production of Shanchol vaccine alarms WHO amid ‘unprecedented’ global outbreaks
The manufacturer of one of only two cholera vaccines for use in humanitarian emergencies is to halt production at the end of this year, just as the world faces an “unprecedented” series of deadly outbreaks, the Guardian has learned.
Shantha Biotechnics, a wholly owned Indian subsidiary of the French pharmaceutical company Sanofi, will stop production of its Shanchol vaccine within months and cease supply by the end of 2023, causing alarm among health officials. Continue reading...
http://dlvr.it/Sb3Xc9
Subscribe to:
Post Comments (Atom)
Insulin100: The Discovery and Development
By Defining Moments Canada The discovery and the development of insulin in the early 1920s by a team of scientists in Canada saved the live...
-
The making—and selling—of Coca-Cola. By E. J. Kahn, Jr. , THE NEW YORKER, Profiles February 6, 1959 Photograph by George Marks / Retrofile...
-
At the New York Times trial, the former governor was impressive at first. It didn’t last. BY SETH STEVENSON | Slate FEB 10, 20228:31 PM S...
No comments:
Post a Comment